Full Content is available to subscribers

Subscribe/Learn More  >
Proceedings Article

FRET as a tool for the investigation of the fate of Lipidots contrast agents in vivo

[+] Author Affiliations
J. Gravier, F. Vinet, I. Texier

CEA-LETI, MINATEC (France)

L. Sancey, J. L. Coll

Institut Albert Bonniot (France)

S. Hirsjärvi, J. P. Benoît

Univ. d'angers (France)

Proc. SPIE 7910, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications III, 79100W (February 11, 2011); doi:10.1117/12.873699
Text Size: A A A
From Conference Volume 7910

  • Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications III
  • Samuel Achilefu; Ramesh Raghavachari
  • San Francisco, California, USA | January 22, 2011

abstract

Different approaches have been reported in the recent years for the in vivo delivery and targeting of poorly soluble contrast agents and active ingredients in diseased tissues. In this context, we developed new lipid nanoparticles (Lipidots®) with size being easily varied from 25 to 120 nm. Lipidots® display numerous advantages: they are composed of low-cost and biocompatible lipids; they can be stored in injection-ready formulations for long duration; their manufacturing process is versatile and up-scalable. Several indocyanines have been efficiently encapsulated in the particles while retaining their spectroscopic properties, with emission wavelengths ranging from 500 to 820 nm. Thus, dye loaded-Lipidots® have been proved suitable for both in vitro and in vivo applications. To better understand Lipidots®' behavior in biological systems, formulations based on Förster Resonance Energy Transfer (FRET) have been studied. Different pairs of the selected indocyanines were co-encapsulated and calculations proved that transfer efficiency within nanoparticles (i) behaves as in a continuous medium; (ii) depends on local acceptor concentration. Thanks to the local dye concentration dependence of FRET, these formulations are used to understand where and when the particles are assimilated in biological systems. FRET-based Lipidots® contrast agents are also promising tools to enhance imaging contrast in vivo by making a clear difference between circulating and uptaken particles.

© (2011) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Citation

J. Gravier ; L. Sancey ; J. L. Coll ; S. Hirsjärvi ; J. P. Benoît, et al.
"FRET as a tool for the investigation of the fate of Lipidots contrast agents in vivo ", Proc. SPIE 7910, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications III, 79100W (February 11, 2011); doi:10.1117/12.873699; http://dx.doi.org/10.1117/12.873699


Access This Proceeding
Sign in or Create a personal account to Buy this proceeding ($15 for members, $18 for non-members).

Figures

Tables

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Advertisement


 

  • Don't have an account?
  • Subscribe to the SPIE Digital Library
  • Create a FREE account to sign up for Digital Library content alerts and gain access to institutional subscriptions remotely.
Access This Proceeding
Sign in or Create a personal account to Buy this proceeding ($15 for members, $18 for non-members).
Access This Proceeding
Sign in or Create a personal account to Buy this article ($15 for members, $18 for non-members).
Access This Chapter

Access to SPIE eBooks is limited to subscribing institutions and is not available as part of a personal subscription. Print or electronic versions of individual SPIE books may be purchased via SPIE.org.